FEN1 and breast cancer: Previous studies have demonstrated that FEN1 single-nucleotide polymorphisms (SNPs) are involved in various cancer developments, including breast cancer [6], lung cancer [4, 7], hepatocellular carcinoma [8], esophageal cancer [9], and gastric cancer [10] as well as glioma [11].